Nyrada Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NYR.AX research report →
Price Chart
About the company
Nyrada Inc. , a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its lead candidate is Xolatryp, a small molecule drug which has completed phase 1 clinical trial for neuroprotection and cardioprotection indications and in patients with traumatic brain injury and ischaemic stroke.
- CEO
- James Bonnar
- IPO
- 2020
- Employees
- 4,000
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on NYR.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $181.23M
- P/E
- -27.19
- PEG
- 2.23
- P/S
- 0.00
- P/B
- 19.00
- EV/EBITDA
- -20.13
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -67.47%
- ROIC
- -68.82%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-3,196+99.8%
- Op Income
- $-8,572,589
- Net Income
- $-6,528,080-34.7%
- EPS
- $-0.03-12.8%
- OCF Growth
- +11.1%
- FCF Growth
- +10.9%
- 52W High
- $1.44
- 52W Low
- $0.23
- 50D MA
- $0.55
- 200D MA
- $0.66
- Beta
- 0.93
- RSI (14)
- 61
- Avg Volume
- 277.30K
No earnings-call transcripts are available for NYR.AX yet.
- Free Float
- 53.4%
- Shares Outstanding
- 243.26M
- Float Shares
- 129.95M
Our NYR.AX coverage
Recent articles, reports, and earnings notes.
No research on NYR.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NYR.AX report →Marcus Frampton Acquires 600,000 Shares of Nyrada (ASX:NYR) Stock
defenseworld.net · Dec 17
Ruediger Weseloh Purchases 600,000 Shares of Nyrada (ASX:NYR) Stock
defenseworld.net · Dec 17
John Moore Buys 1,200,000 Shares of Nyrada (ASX:NYR) Stock
defenseworld.net · Dec 17
Christopher Cox Buys 600,000 Shares of Nyrada (ASX:NYR) Stock
defenseworld.net · Dec 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.